{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Phoenix",
      "state": "AZ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "96996",
      "recalling_firm": "Tailstorm Health INC",
      "address_1": "24416 N 19th Ave Ste 200",
      "address_2": "",
      "postal_code": "85085-1400",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "",
      "distribution_pattern": "Nationwide in the US",
      "recall_number": "D-0500-2025",
      "product_description": "KETAmine Hydrochloride Injection, USP, 50 mg/5mL (10 mg/mL), For IM Use or Slow IV Use, 5 mL Sterile Single-Dose Vial, Rx Only, For Office Use Only, Compounded Durg by: Medivant Healthcare, 158 S. Kyrene Rd. Chandler, AZ 85226, NDC 81483-0006-0.",
      "product_quantity": "23,200 vials",
      "reason_for_recall": "Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.",
      "recall_initiation_date": "20250602",
      "center_classification_date": "20250630",
      "report_date": "20250709",
      "code_info": "Lot #s: 2502008, Exp. 2/27/2027; 2503001, Exp. 3/4/2027.",
      "more_code_info": ""
    }
  ]
}